Adaptive Biotechnologies ADPT 深 滬
交易中 04-23 11:57:59 美东时间
13.75
-0.450
-3.17%
華盛通- 最 高14.40
- 今 開14.18
- 成交量 25.05万股
- 最 低 13.62
- 昨 收 14.20
- 總市值 21.17亿
- 52周最高 20.76
- 市盈率 靜 --
- 換手率 0.16%
- 52周最低 8.375
- 委 比 -98.40%
- 總股本 1.54亿
- 歷史最高 71.25
- 量 比 0.54
- 振 幅 5.49%
- 歷史最低 2.28
- 每 手 1
- 風險率 3.02%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多U.S. RESEARCH ROUNDUP-Biogen, Equinix, Revolution Medicines
U.S. RESEARCH ROUNDUP-Biogen, Equinix, Revolution Medicines April 14 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Biogen, Equinix and Revolution Medicines on Tuesday. HIGHLIGHTS * Biogen BIIB.O : Piper Sandler raises
04-14 15:45
Mid-cap healthcare stocks with A grade EPS revisions ahead of earnings
As Q1 2026 earnings season approaches, the healthcare sector enters reporting season as one of the market's primary laggards, with the Health Care Select Sector SPDR Fund (XLV) down 5.29% in Q1 2026, ...
04-11 05:14
Adaptive Biotechnologies launches clonoSEQ MRD test for blood cancers
Adaptive Biotechnologies launches clonoSEQ MRD test for blood cancers Adaptive highlighted clonoSEQ as a measurable residual disease test positioned to support treatment decisions across multiple blood cancer settings, with commercialization supported by FDA clearances in multiple myeloma, ALL, and
03-25 08:51
Adaptive Biotechnologies President and COO Julie Rubinstein Disposes of Common Shares
Adaptive Biotechnologies President and COO Julie Rubinstein Disposes of Common Shares Julie Rubinstein, President and COO of Adaptive Biotechnologies Corporation, reported a disposal of the company’s common shares. The full filing can be accessed through the link below. Disclaimer: This news brief w
03-14 09:37
Adaptive Biotechnologies Director Michelle Renee Griffin Disposes of Common Shares
Adaptive Biotechnologies Director Michelle Renee Griffin Disposes of Common Shares Michelle Renee Griffin, a director, reported a disposal of common shares of Adaptive Biotechnologies Corporation. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Publ
03-14 09:05
Adaptive Biotechnologies Chief People Officer Francis Lo Disposes of Common Shares
Adaptive Biotechnologies Chief People Officer Francis Lo Disposes of Common Shares Francis Lo, Chief People Officer of Adaptive Biotechnologies Corporation, reported a disposal of common shares. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public
03-14 09:02
Adaptive Biotechnologies CEO and Chairman Chad M. Robins Disposes of Common Shares
Adaptive Biotechnologies CEO and Chairman Chad M. Robins Disposes of Common Shares Chad M. Robins, CEO and Chairman of Adaptive Biotechnologies Corporation, reported a disposal of the company’s common shares. The full filing can be accessed through the link below. Disclaimer: This news brief was cre
03-04 08:52
财报速睇 | Adaptive Biotechnologies 2025财年年度营收2.77亿美元，同比增长54.7%；归母净利润亏损0.60亿美元，同比亏损缩窄62.7%
华盛资讯2月27日讯，Adaptive Biotechnologies公布2025财年年度业绩，公司年度营收2.77亿美元，同比增长54.7%，归母净利润亏损0.60亿美元，同比亏损缩窄62.7%。
02-27 12:56
10x Genomics Earnings Preview
10x Genomics (NASDAQ:TXG) is set to give its latest quarterly earnings report o...
02-12 02:02
美股大行评级 | 遭多家大行下调目标价！亚马逊、Affirm、Roblox、汤森路透、Doximity、OneMain、Atlassian、Peloton等等
今日重点评级关注：HC Wainwright & Co.：维持NovaBridge Biosciences"买入"评级，目标价从7美元升至9美元；Truist Securities：维持Reddit"买入"评级，目标价从270美元升至275美元
02-09 14:37
